[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335922-105":59,"doc-detail-335922-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","malignancy-related-ascites-in-palliative-care-units-prognostic-factor-analysis","Malignancy-related ascites in palliative care units - prognostic factor analysis","","Objectives This post hoc analysis evaluated prognostic impacts of malignancy-related ascites (MA) in terminally ill cancer patients and identified prognostic factors within the MA cohort. Methods Patients with advanced cancer admitted to palliative care units at 23 institutions (age ≥18) from January to December 2017 were analyzed by overall survival, with multivariate modeling for MA-specific factors. Results Among 1896 eligible patients, 568 (30.0%) had MA, associated with shorter survival and a poor prognostic effect. Additional findings highlighted clinical and laboratory predictors. Conclusions MA negatively affected survival, and multivariate analysis revealed multiple prognostic factors in terminal cancer patients with MA.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/malignancy-related-ascites-in-palliative-care-units-prognostic-factor-analysis/335922/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/malignancy-related-ascites-in-palliative-care-units-prognostic-factor-analysis/335922.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of this study?","Question",{"text":112,"@type":113},"To evaluate how malignancy-related ascites (MA) affects prognosis in terminally ill cancer patients and to identify prognostic factors among patients with MA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was overall survival analyzed in relation to MA?",{"text":117,"@type":113},"Overall survival was compared between patients with and without MA, and a multivariate analysis was performed to explore MA-specific prognostic factors.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about the impact of MA on survival?",{"text":121,"@type":113},"Patients with MA had significantly shorter overall survival than those without MA, and MA was identified as a poor prognostic factor in multivariate analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335922,1790645724,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Original research  \nMalignancy-related ascites in palliative care units: prognostic factor analysis  \nToru Kadono  , 1,2 Hiroto Ishiki,2 Naosuke Yokomichi,3 Tetsuya Ito,4,5 Isseki Maeda,6 Yutaka Hatano  ,7 Tomofumi Miura  ,8 Jun Hamano  ,9 Takashi Yamaguchi, 10 Ayaka Ishikawa,2 Yuka Suzuki,2 Sayaka Arakawa,2 Koji Amano,2 Eriko Satomi,2 Masanori Mori3  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Hiroto Ishiki, Department of palliative medicine, National Cancer Center Japan, Chuo-ku, Tokyo 104-0045, Japan; [hishiki@ncc.go.jp](hishiki@ncc.go.jp)  \nReceived 20 March 2023 Accepted 23 March 2023 Published Online First 20 April 2023  \n© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nTo cite: Kadono T, Ishiki H, Yokomichi N, et al. BMJ Supportive & Palliative Care 2023;13:e1292–e1299 .  \nABSTRACT  \nObjectives The prognostic factors in patients with malignancy-related ascites (MA) have been poorly investigated. This study aimed to evaluate both the prognostic impact of MA on terminally ill patients with cancer and the prognostic factors in those with MA.  \nMethods This was a post hoc analysis of amulticentre, prospective cohort study. Patients with advanced cancer admitted to palliative care units at 23 institutions and aged≥18 years were enrolled between January and December 2017. Overall survival (OS) was compared according to MA. A multivariate analysis was conducted to explore prognostic factors in patients with MA. Results Of 1896 eligible patients, gastrointestinal and hepatobiliary pancreatic cancers accounted for 42. 5% . 568 (30 .0%) of the total had MA. Patients with MA had significantly shorter OS than those without MA (median, 14 vs 22 days, respectively; HR, 1. 55; 95% CI, 1.39 to 1. 72; p\u003C0 .01) . A multivariate analysis showed that MA was a poor prognostic factor (HR, 1.30; 95% CI, 1.13 to 1. 50; p\u003C0 .01) and that among patients with MA, significant poor prognostic factors were liver metastasis, moderately to severely reduced oral intake, delirium, oedema, gastric cancer, high serum creatinine, high serum C reactive protein, high serum total bilirubin, dyspnoea and fatigue, while significant good prognostic factors were female sex, good performance status, high serum albumin and colorectal cancer. Conclusions MA had a negative impact on survival in terminally ill patients with cancer. A multivariate analysis revealed several prognostic factors in patients with terminal cancer and MA.  \nINTRODUCTION  \nMalignancy-related ascites (MA) accounts for about 10% of all ascites cases.1 MA is usually caused by peritoneal  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Malignancy-related ascites (MA) accounts for about 10% of all ascites cases.\u003Cbr>⇒ MA is associated with a poor prognosis.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ Evaluating the prognostic impact of MA on terminally ill patients with cancer.\u003Cbr>⇒ Investigating prognostic factors.\u003Cbr>HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY |\n\n⇒ Accurate prediction of prognosis.  \n⇒ Indicators in palliative treatment for patients with MA.  \ncarcinomatosis and less commonly by portal hypertension due to massive liver metastases, liver cirrhosis with hepatocellular carcinoma and chylous ascites with malignant lymphoma.2 MA often occurs in the end stage of gastrointestinal and ovarian cancers and causes various symptoms such as abdominal swelling and pain, nausea, anorexia, vomiting and dyspnoea.3 The median survival time after MA diagnosis ranges from 1 to 4 months.4 While MA is associated with a poor prognosis and deterioration in quality of life, the prognostic factors in patients with MA have been poorly investigated. No prospective studies have explored this issue. A retrospective study showed that liver metastasis and low serum albumin (Alb) level were poor prognostic factors in patients with MA, while ovarian cancer was a good prognostic factor.2 Mor","cbCailjXV82Sacxn","https://ap.wps.com/l/cbCailjXV82Sacxn","pdf",1335769,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Background on MA and prognosis\n## Chemotherapy considerations and research gap\n# What this study adds\n## Accurate prediction of prognosis","[{\"question\":\"What was the main objective of this study?\",\"answer\":\"To evaluate how malignancy-related ascites (MA) affects prognosis in terminally ill cancer patients and to identify prognostic factors among patients with MA.\"},{\"question\":\"How was overall survival analyzed in relation to MA?\",\"answer\":\"Overall survival was compared between patients with and without MA, and a multivariate analysis was performed to explore MA-specific prognostic factors.\"},{\"question\":\"What did the study find about the impact of MA on survival?\",\"answer\":\"Patients with MA had significantly shorter overall survival than those without MA, and MA was identified as a poor prognostic factor in multivariate analysis.\"}]","Malignancy-related ascites in palliative care units - prognostic factor analysis | PDF",1790012846]